Benobio Co., Ltd.
🇰🇷South Korea
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
- First Posted Date
- 2023-04-07
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Benobio Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT05803785
- Locations
- 🇦🇺
Benobio Investigational site, Sydney, New South Wales, Australia
🇦🇺Sydney Hospital, Sydney, Australia
News
No news found